6 followers
Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical stu... Read more
Willie Quinn
Kura Oncology
20 followers
Halozyme Therapeutics
6 followers
Immunovant
6 followers
REVOLUTION Medicines
5 followers
C4 Therapeutics
5 followers
Summit Therapeutics
5 followers
Inari
3 followers
Beta Bionics
3 followers
Arcturus Therapeutics
2 followers
Tenaya Therapeutics
2 followers
Generation Bio
2 followers
Explore companies